PACIRA BIOSCIENCES, INC. Royalty Expense
PACIRA BIOSCIENCES, INC. (PCRX) reported Royalty Expense of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2018-02-28
- PACIRA BIOSCIENCES, INC. royalty expense for the quarter ending 2016-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. royalty expense for the quarter ending 2016-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. royalty expense for the quarter ending 2016-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. royalty expense for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- PACIRA BIOSCIENCES, INC. royalty expense for fiscal 2017 was $0.00.
- PACIRA BIOSCIENCES, INC. royalty expense for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- PACIRA BIOSCIENCES, INC. royalty expense for fiscal 2015 was $71.00K, a 78.02% decline from fiscal 2014.
- PACIRA BIOSCIENCES, INC. royalty expense for fiscal 2014 was $323.00K, a 48.15% decline from fiscal 2013.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 10-K · filed 2018-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-02 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $71.00K 10-K · filed 2018-02-28 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $71.00K 10-Q · filed 2016-11-02 | $394.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | $71.00K 10-Q · filed 2016-08-04 | $394.00K derived: sum of 3 quarters · filed 2017-03-01 | $467.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $71.00K 10-Q · filed 2016-05-02 | $394.00K derived: sum of 2 quarters · filed 2017-03-01 | $467.00K derived: sum of 3 quarters · filed 2017-03-01 | $603.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $323.00K 10-K · filed 2017-03-01 | $396.00K derived: sum of 2 quarters · filed 2017-03-01 | $532.00K derived: sum of 3 quarters · filed 2017-03-01 | $323.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $73.00K 10-Q · filed 2015-10-27 | $209.00K derived: sum of 2 quarters · filed 2015-10-27 | $330.00K 10-Q · filed 2015-10-27 | $573.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $136.00K 10-Q · filed 2015-07-30 | $256.00K 10-Q · filed 2015-07-30 | $500.00K derived: sum of 3 quarters · filed 2016-02-25 | $632.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $120.00K 10-Q · filed 2015-04-30 | $364.00K derived: sum of 2 quarters · filed 2016-02-25 | $496.00K derived: sum of 3 quarters · filed 2016-02-25 | $657.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $376.00K derived: sum of 2 quarters · filed 2016-02-25 | $537.00K derived: sum of 3 quarters · filed 2016-02-25 | $623.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | $132.00K 10-Q · filed 2014-10-30 | $293.00K derived: sum of 2 quarters · filed 2014-10-30 | $379.00K 10-Q · filed 2014-10-30 | $610.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $161.00K 10-Q · filed 2014-07-31 | $247.00K 10-Q · filed 2014-07-31 | $478.00K derived: sum of 3 quarters · filed 2015-02-24 | $100.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $86.00K 10-Q · filed 2014-05-01 | $317.00K derived: sum of 2 quarters · filed 2015-02-24 | -$61.00K derived: sum of 3 quarters · filed 2015-02-24 | $82.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$147.00K derived: sum of 2 quarters · filed 2015-02-24 | -$4.00K derived: sum of 3 quarters · filed 2015-02-24 | $278.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | -$378.00K 10-Q · filed 2013-10-31 | -$235.00K derived: sum of 2 quarters · filed 2013-10-31 | $47.00K 10-Q · filed 2013-10-31 | $55.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $143.00K 10-Q · filed 2013-08-06 | $425.00K 10-Q · filed 2013-08-06 | $433.00K derived: sum of 3 quarters · filed 2014-02-25 | $317.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $282.00K 10-Q · filed 2013-05-08 | $290.00K derived: sum of 2 quarters · filed 2014-02-25 | $174.00K derived: sum of 3 quarters · filed 2014-02-25 | -$255.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$108.00K derived: sum of 2 quarters · filed 2014-02-25 | -$537.00K derived: sum of 3 quarters · filed 2014-02-25 | -$227.00K 10-K · filed 2014-02-25 |
| 2011-09-30 | -$116.00K 10-Q · filed 2012-11-01 | -$545.00K derived: sum of 2 quarters · filed 2012-11-01 | -$235.00K 10-Q · filed 2012-11-01 | -$352.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | -$429.00K 10-Q · filed 2012-08-09 | -$118.00K 10-Q · filed 2012-08-09 | -$236.00K derived: sum of 3 quarters · filed 2013-03-07 | $208.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $311.00K 10-Q · filed 2012-05-09 | $193.00K derived: sum of 2 quarters · filed 2013-03-07 | $637.00K derived: sum of 3 quarters · filed 2013-03-07 | $1.07M derived: sum of 4 quarters · filed 2013-03-07 |
| 2010-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $326.00K derived: sum of 2 quarters · filed 2013-03-07 | $759.00K derived: sum of 3 quarters · filed 2013-03-07 | $930.00K 10-K · filed 2013-03-07 |
| 2010-09-30 | $444.00K 10-Q · filed 2011-10-31 | $877.00K derived: sum of 2 quarters · filed 2011-10-31 | $1.05M 10-Q · filed 2011-10-31 | |
| 2010-06-30 | $433.00K 10-Q · filed 2011-08-11 | $605.00K 10-Q · filed 2011-08-11 | ||
| 2009-12-31 | $1.88M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |